Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
ETON stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.57B
- P/E (TTM)
- 137.20
- Forward P/E
- 21.27
- EPS (TTM)
- $0.40
- Dividend yield
- None
- 52-week range
- 14.27 – 66.37
- Day range
- 53.55 – 56.42
- Volume / Avg
- 713.87K / 600.23K
- Beta
- —
- Shares outstanding
- 28.58M
- Next earnings
- Nov 5, 2026
52-week range
ETON stock today
Shares of Eton Pharmaceuticals (ETON) finished higher on Oct 7 at $54.88, a gain of 0.20% or $0.11 per share, versus the S&P 500's 0.22% decline. At this level, ETON sits in the middle of its 52-week range of $14.27 to $66.37: 17.3% below the high, set on Aug 24, 2026 and 284.6% above the low. ETON is up 224.5% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 159.5%.
Eton Pharmaceuticals trades at 137.2x its trailing twelve-month earnings per share of $0.40. Its forward P/E of 21.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Eton Pharmaceuticals's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Eton Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.34
Eton Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| STOKStoke Therapeutics Inc. | 24.29 | -0.33% | $1.57B | vs ETON |
| OCULOcular Therapeutix Inc. | 7.23 | -1.50% | $1.59B | vs ETON |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs ETON |
| QUREuniQure N.V. | 23.14 | +0.35% | $1.61B | vs ETON |
| INVAInnoviva Inc. | 21.06 | +1.10% | $1.52B | vs ETON |
| SNDXSyndax Pharmaceuticals Inc. | 17.03 | -1.96% | $1.52B | vs ETON |
| CMPSCOMPASS Pathways Plc American Depository Shares | 11.69 | +1.12% | $1.62B | vs ETON |
| RAPPRapport Therapeutics Inc. | 30.86 | -0.93% | $1.48B | vs ETON |
Indexes, lists and sector
Eton Pharmaceuticals stock FAQ
What is Eton Pharmaceuticals's stock price today?
ETON last traded at $54.88 as of Oct 7, 4:00 PM EDT, up 0.20% on the day. Prices are delayed at least 15 minutes.
When is Eton Pharmaceuticals's next earnings date?
Eton Pharmaceuticals is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.34.
What is ETON's P/E ratio?
ETON trades at a trailing P/E ratio of 137.20 and a forward P/E of 21.27.
What is the ETON 52-week high?
The 52-week high for ETON is $66.37 and the 52-week low is $14.27. The stock is currently 17.3% below its high.